Efficacy and Safety Trial of Verubecestat (MK-8931) in Participants With Prodromal Alzheimer's Disease (MK-8931-019)



Status:Recruiting
Conditions:Alzheimer Disease, Cognitive Studies
Therapuetic Areas:Neurology, Psychiatry / Psychology
Healthy:No
Age Range:50 - 85
Updated:8/12/2016
Start Date:November 2013
End Date:March 2021
Contact:Toll Free Number
Phone:1-888-577-8839

Use our guide to learn which trials are right for you!

A Phase III, Randomized, Placebo-Controlled, Parallel-Group, Double-Blind Clinical Trial to Study the Efficacy and Safety of MK-8931 (SCH 900931) in Subjects With Amnestic Mild Cognitive Impairment Due to Alzheimer's Disease (Prodromal AD)

This study consists of two parts, Part I and Part II. The purpose of Part I of the study is
to assess the efficacy and safety of verubecestat (MK-8931) compared with placebo
administered for 104 weeks in the treatment of amnestic mild cognitive impairment (aMCI) due
to Alzheimer's Disease (AD), also known as prodromal AD. Participants will be randomized to
receive placebo, or 12 mg or 40 mg verubecestat, once daily. The primary study hypothesis
for Part 1 is that at least one verubecestat dose is superior to placebo with respect to the
change from baseline in the Clinical Dementia Rating scale-Sum of Boxes (CDR-SB) score at
104 weeks. Participants who complete Part I of the study may choose to participate in Part
II, which is a long term double-blind extension to assess efficacy and safety of
verubecestat administered for up to an additional 260 weeks. In Part II, all participants
will receive either 12 mg or 40 mg verubecestat, once daily.

Two substudies are included in the study protocol: 1) a PET medical imaging substudy using
an amyloid tracer ([18F]flutemetamol) to evaluate changes in brain composite cortical
amyloid standard uptake value ratio; and 2) a companion diagnostic substudy using Luminex
investigational xMAP™ Tau/Amyloid Assay to evaluate response to treatment in CSF positive
participants (i.e., those with defined tau:amyloid-β42 ratio in CSF) and changes in CSF
concentrations of amyloid-β related peptides, total tau and phosphorylated tau (Substudy
Title: A Companion Diagnostic Clinical Study of Luminex xMAP™ Tau/Amyloid Assay in Subjects
with Amnestic Mild Cognitive Impairment due to Alzheimer's Disease [Prodromal AD] who are
Enrolled into Merck MK-8931 Pivotal Phase III Clinical Trial [Study No. MK-8931-019]). The
substudies will be conducted only at designated investigational sites. Participants are not
required to take part in a substudy in order to take part in the larger trial.

Inclusion Criteria:

1. Diagnosis of prodromal AD, including the following:

1. History of subjective memory decline with gradual onset and slow progression for
at least one year corroborated by an informant,

2. Objective impairment in episodic memory by memory test performed at Screening,

3. Does not meet criteria for dementia, AND

4. Positive Screening amyloid imaging PET scan using [18F]flutametamol tracer or
positive Screening CSF tau:amyloid-β42 (Aβ42) ratio

2. Able to read at a 6th grade level or equivalent

3. If participant is receiving an acetylcholinesterase inhibitor or memantine, the dose
must have been stable for at least three months before Screening

4. Must have a reliable and competent trial partner/informant who has a close
relationship with the participant and is willing to accompany the participant to all
required trial visits, and to monitor compliance of the administration of the trial
medication

5. Agree to inform their general practitioner of their participation in this study

Inclusion Criteria for Extension Period (Part II):

1. Tolerated study drug and completed the initial 104-week period of the trial (Part I)

2. Participant must have a reliable and competent trial partner who must have a close
relationship with the subject

Exclusion Criteria:

1. History of stroke

2. Evidence of a clinically relevant neurological disorder other than the disease being
studied (i.e., prodromal AD)

3. History of seizures or epilepsy within the last 5 years

4. Evidence of a clinically relevant or unstable psychiatric disorder, excluding major
depression in remission

5. Participant is at imminent risk of self-harm or of harm to others

6. History of alcoholism or drug dependency/abuse within the last 5 years before
Screening

7. Participant does not have a magnetic resonance imaging (MRI) scan obtained within 12
months of Screening and is unwilling or not eligible to undergo an MRI scan at the
Screening Visit. With Sponsor approval, a head computed tomography (CT) scan may be
substituted for MRI scan to evaluate eligibility

8. History of hepatitis or liver disease that has been active within the 6 months prior
to Screening

9. Recent or ongoing, uncontrolled, clinically significant medical condition within 3
months of Screening

10. History of malignancy occurring within the 5 years before Screening, except for
adequately treated basal cell or squamous cell skin cancer, in situ cervical cancer,
or localized prostate carcinoma

11. Clinically significant vitamin B12 or folate deficiency in the 6 months before
Screening

12. Use of any investigational drugs or participation in clinical trials within the 30
days before Screening

13. History of a hypersensitivity reaction to more than three drugs

14. Has human immunodeficiency virus (HIV) by medical history

15. Participant is unwilling or has a contraindication to undergo PET scanning including
but not limited to claustrophobia, excessive weight or girth

16. History or current evidence of long QT syndrome, corrected QT (QTc) interval ≥470
milliseconds (for male participants) or ≥480 milliseconds (for female participants),
or torsades de pointes

17. Close family member (including the trial partner, spouse or children) who is among
the personnel of the investigational or sponsor staff directly involved with this
trial

Exclusion Criteria for Extension Period (Part II):

1. Participant is at imminent risk of self-harm or of harm to others

2. Has developed a recent or ongoing, uncontrolled, clinically significant medical or
psychiatric condition

3. Results of safety assessments (e.g., laboratory tests) performed in participant at
end of Part I that are clinically unacceptable to the Investigator

4. Has developed a form of dementia that is not AD
We found this trial at
72
sites
?
mi
from
Allentown, PA
Click here to add this to my saved trials
?
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
?
mi
from
Atlanta, GA
Click here to add this to my saved trials
?
mi
from
Baltimore, MD
Click here to add this to my saved trials
?
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
?
mi
from
Boston, MA
Click here to add this to my saved trials
Buenos Aires,
Phone: 54 11 4796 8200
?
mi
from
Buenos Aires,
Click here to add this to my saved trials
?
mi
from
Canton, OH
Click here to add this to my saved trials
Charleston, South Carolina 29412
?
mi
from
Charleston, SC
Click here to add this to my saved trials
Charlotte, North Carolina 28207
?
mi
from
Charlotte, NC
Click here to add this to my saved trials
?
mi
from
Charlottesville, VA
Click here to add this to my saved trials
?
mi
from
Chicago, IL
Click here to add this to my saved trials
?
mi
from
Cincinnati, OH
Click here to add this to my saved trials
?
mi
from
Columbus, OH
Click here to add this to my saved trials
?
mi
from
Dallas, TX
Click here to add this to my saved trials
?
mi
from
Dallas, TX
Click here to add this to my saved trials
?
mi
from
Delray Beach, FL
Click here to add this to my saved trials
?
mi
from
Durham, NC
Click here to add this to my saved trials
Elk Grove Village, Illinois 60007
?
mi
from
Elk Grove Village, IL
Click here to add this to my saved trials
?
mi
from
Encino, CA
Click here to add this to my saved trials
?
mi
from
Fayetteville, AR
Click here to add this to my saved trials
?
mi
from
Fullerton, CA
Click here to add this to my saved trials
?
mi
from
Gilbert, AZ
Click here to add this to my saved trials
?
mi
from
Hialeah, FL
Click here to add this to my saved trials
?
mi
from
Hollywood, FL
Click here to add this to my saved trials
?
mi
from
Kingsport, TN
Click here to add this to my saved trials
?
mi
from
La Jolla, CA
Click here to add this to my saved trials
?
mi
from
Long Beach, CA
Click here to add this to my saved trials
?
mi
from
Los Angeles, CA
Click here to add this to my saved trials
?
mi
from
Madison, WI
Click here to add this to my saved trials
?
mi
from
Manhasset, NY
Click here to add this to my saved trials
?
mi
from
Miami Beach, FL
Click here to add this to my saved trials
Mt. Arlington, New Jersey 07856
?
mi
from
Mt. Arlington, NJ
Click here to add this to my saved trials
?
mi
from
Naples, FL
Click here to add this to my saved trials
?
mi
from
Nashville, TN
Click here to add this to my saved trials
?
mi
from
New Haven, CT
Click here to add this to my saved trials
?
mi
from
New York, NY
Click here to add this to my saved trials
?
mi
from
New York, NY
Click here to add this to my saved trials
?
mi
from
New York, NY
Click here to add this to my saved trials
?
mi
from
Norristown, PA
Click here to add this to my saved trials
?
mi
from
Ocala, FL
Click here to add this to my saved trials
?
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
?
mi
from
Orangeburg, NY
Click here to add this to my saved trials
?
mi
from
Orlando, FL
Click here to add this to my saved trials
?
mi
from
Ormond Beach, FL
Click here to add this to my saved trials
Palm Beach Gardens, Florida 33410
?
mi
from
Palm Beach Gardens, FL
Click here to add this to my saved trials
?
mi
from
Phoenix, AZ
Click here to add this to my saved trials
?
mi
from
Phoenix, AZ
Click here to add this to my saved trials
?
mi
from
Plains, PA
Click here to add this to my saved trials
?
mi
from
Portland, OR
Click here to add this to my saved trials
?
mi
from
Princeton, NJ
Click here to add this to my saved trials
?
mi
from
Providence, RI
Click here to add this to my saved trials
?
mi
from
Providence, RI
Click here to add this to my saved trials
?
mi
from
Rochester, NY
Click here to add this to my saved trials
?
mi
from
Rochester, NY
Click here to add this to my saved trials
?
mi
from
Sacramento, CA
Click here to add this to my saved trials
?
mi
from
Saint Paul, MN
Click here to add this to my saved trials
?
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
?
mi
from
Shaker Heights, OH
Click here to add this to my saved trials
?
mi
from
Sherman Oaks, CA
Click here to add this to my saved trials
?
mi
from
Simi Valley, CA
Click here to add this to my saved trials
?
mi
from
Staten Island, NY
Click here to add this to my saved trials
?
mi
from
Sun City, AZ
Click here to add this to my saved trials
?
mi
from
Tampa, FL
Click here to add this to my saved trials
?
mi
from
Tampa, FL
Click here to add this to my saved trials
?
mi
from
Toms River, NJ
Click here to add this to my saved trials
?
mi
from
Topeka, KS
Click here to add this to my saved trials
?
mi
from
Tulsa, OK
Click here to add this to my saved trials
Valley Village, California 91607
?
mi
from
Valley Village, CA
Click here to add this to my saved trials
?
mi
from
Washington,
Click here to add this to my saved trials
?
mi
from
West Long Branch, NJ
Click here to add this to my saved trials
Willow Grove, Pennsylvania 19090
?
mi
from
Willow Grove, PA
Click here to add this to my saved trials